Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:February 7, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:February 7, 2024Recruiting
Condition(s):MyelomaLast Updated:August 21, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:March 5, 2024Active, not recruiting
Condition(s):Lymphoproliferative Disorder; HHV-8; Malignancy; HIVLast Updated:March 21, 2024Active, not recruiting
Condition(s):MyelomaLast Updated:June 30, 2022Active, not recruiting
Condition(s):Multiple Myeloma; Primary Plasma Cell Leukemia; Extramedullary Multiple MyelomaLast Updated:January 3, 2024Recruiting
Condition(s):High-Risk de Novo Multiple MyelomaLast Updated:November 29, 2023Recruiting
Condition(s):Hematologic Neoplasms; Multiple Myeloma; Efficacy; SafetyLast Updated:November 29, 2019Unknown status
Condition(s):MyelomaLast Updated:January 15, 2014Completed
Condition(s):Waldenstrom MacroglobulinemiaLast Updated:April 13, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.